drugset / Trial / NCT00214825
Aldosterone and Vascular Disease in Diabetes Mellitus
RandomizedCrossoverDouble-blindTreatment
Summary
Specific aims for this proposal are to determine in patients with diabetes mellitus the effects of an aldosterone receptor antagonist on: 1. Coronary microvascular function assessed by MRI perfusion reserve, 2. Endothelial dysfunction assessed by brachial artery reactivity studies, and 3. Inflammation assessed by blood measurements of c-reactive protein (CRP), monocyte chemoattractant protein-1 (MCP-1), and plasminogen activator inhibitor-1 (PAI-1).
Timeline
- Start
- 2003-08
- Primary completion
- 2006-03
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eplerenone | Unknown | 50 mg | — |
| Comparator | Hydrochlorothiazide | Unknown | 12.5 mg | — |